This episode of The Intelligence from The Economist covers two main stories: the competition between Novo Nordisk and Eli Lilly in the weight loss drug market, detailing Novo Nordisk's missteps and strategic changes, and a look into the British wool industry, exploring its historical significance, recent price increases due to demand and supply factors, and the impact of sheep well-being on wool quality. The podcast analyzes market dynamics, corporate strategies, and economic trends in these distinct sectors.
Outlines
Sign in to continue reading, translating and more.
Open full episode in Podwise